Fungal Infection Flashcards
Mucormycoses Risk
Uncontroll DM
Bone marrow or solid organ transplantation
Fe overload or having defroxamine
Systemic steroid use
Endemic Mycoses general treatment guild
Acute pulmonary histoplasmosis and coccidioidomycosis often required no treatment in healthy individual
All blastomycosis required aggressitreatment
Histoplasmosis treatment
Treatment should be provid to Pt who do not improve after 1 month or who exhibit hypoxia.
DOT 12-24 months
1st line: Itraconazole 200mg PO TID X 3 days then 200mg PO BID/ Daily
Liposomal AMB: 3-5 mg/kg IV daily, may switch to PO when tolerated
ABPA - diagnosis
not a true infection but an IgE-mediated hypersensitivity response
can progress to fibrotic end-stage lung disease with honeycomb lung tissue
Cough, wheezing, increase production of sputum
respiratory sample: elevated IgE levels to >500 units/ml IgG or IgE antibodies can be detected to aid in diagnosis
Endemic mycoses diagnosis
The best way to diagnosis these mycoses is through tissue biopsy and looking for fungal structure on histology examination, as well as culture from sputum/ BAL samples
Coccidioidomycosis: erythema dodosum (dark blotched skin ) on shins or lower extremities, arthrlagias
Often test for seology testing for IgG and IgM antibodies, however, they are not specific to currently active infection
forms characteristic structure in tissues called “spherules” that reliably diagnostic of valley fever
Hisoplasma and blastomyces can be teste for with a urinary antigen test, a;though sensitivity and specificity is not ideal
Candidiasis - Echinocandins indication
neutropenic patients,
patients with recent azole exposure, who are hemodynamically unstable,
currently hospitalized at an institution where >15% of Candida isolates are either C. glabrata or C. krusei.
Coccidioidomycosis treatment
Pulmonary disease should be treated for 6 months
disseminated disease 12 months
lifelong suppressive therapy is needed in cocci meningitis
Fluconazole 400mg PO daily
Liposomal AMB: 3-5mg/kg IV daily, may switch to PO when clinically improved and tolerates PO
Alternative: Itraconazole 200mg PO BID
Oropharyngeal candidiasis non-sys treatment
clotrimazole troches 10mg 5X/day
Nystatin suspension 400,000-600,000 IU swish and spit QID for 7-14 days
Pulmonary Mucormycosis
Hemoptysis with pulmonary hemorrhage
X-ray with infiltrate and cavity
Cavitation may occur as immunosuppression resolves
May spread through body in a contiguous fashion
Mucormycoses treatment
aggressive surgical debridement
DOC: AMB (AmBisome) at least 14 days
Maintenance: posaconazole 200mg PO q6hr
Aspergillosis risk
Cystic fibrosis ans structure lung
Prolonged and profound neutropenia ( absolute neutrophils <100 cells/mm3)
advanced HIV infection
Solid organ or bone marrow transplantation
GVHD of the lung
complicated VVC - difination
more than 4 episode/ yr infection due to non-albicans spp in DM, Pregnancy, immunosuppression Pt.
Aspergillosis presentation and Diagnosis
Pneumonia - multiple nodular infiltrates on chest CT scans
Pathologic tissue sample grow 24-72 hrs
+ tissue biopsy show invasion of host tissue with hyphae IPA
SOB, bloody cough,
CT is preferred over CXR
Candidiasis - Echinocandins dosage
Micafugin: 100mg IV daily
Caspofugin: LD 70mg then 50 mg IV daily
Anidulafungin: LD 200mg then 100mg IV daily
IPA treatment
DOC:
Voriconazole 6mg/kg IV BID x2 then 4mg/kg IV BID or 200mg PO BID
Added AMB lipid for severe:3-5mg/kg IV daily can be Monotherapy
If Vfen not tolerated
Itraconazole
Posaconazole 200mg po ss QID then 400mg
PO BID 300 mg DR/IV BID X2 then 300mg PO daily may be alternative
Coricosteroids must be avoided
DOT: at least 6-12 weeks but most receive for at least 6 months